Clindamycin Palmitate

CHEMBL1201289 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

663.4 g/mol

LogP

10.1

Phase

4

An inactive form of the antibiotic clindamycin that is converted to its active parent compound after absorption. It is used to treat bacterial infections caused by certain anaerobic bacteria and gram-positive organisms, including skin and respiratory tract infections. This salt form is most commonly used in oral liquid preparations for easier dosing.

분자량

663.4000 g/mol

LogP

10.10

TPSA

134.00 Å²

리핀스키 5의 법칙

불통과

치료 영역

Endometriosis Pain Management Rheumatoid Arthritis Asthma Insomnia Obesity Lymphoma Hypertension Breast Cancer Chronic Pain Malaria Heart Failure Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC

InChI

InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/t24-,25+,26-,28+,29+,30-,31+,32+,34+/m0/s1

Molecular Formula

C34H63ClN2O6S

HBD / HBA

3 / 8

회전 가능 결합

23

무거운 원자

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

An inactive form of the antibiotic clindamycin that is converted to its active parent compound after absorption. It is used to treat bacterial infections caused by certain anaerobic bacteria and gram-positive organisms, including skin and respiratory tract infections. This salt form is most commonly used in oral liquid preparations for easier dosing.

Yes, Clindamycin Palmitate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201289. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 16052039. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Clindamycin Palmitate PillFYI에서

구조

핵심 데이터

분자식: C34H63ClN2O6S
동의어: 3

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.